MCT4 as a potential therapeutic target to augment gemcitabine chemosensitivity in resected pancreatic cancer

被引：0
|
作者：
Sung Hwan Lee
Ho Kyoung Hwang
Woo Jung Lee
Chang Moo Kang
机构：
[1] CHA Bundang Medical Center,Department of Surgery
[2] CHA University School of Medicine,Laboratory of HBP Integrative Precision Oncology
[3] CHA Bio Complex,Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery
[4] CHA Health System,Pancreatobiliary Cancer Center
[5] Yonsei University College of Medicine,undefined
[6] Yonsei Cancer Center,undefined
[7] Severance Hospital,undefined
来源：
Cellular Oncology | 2021年 / 44卷
关键词：
Pancreatic cancer; MCT4; Gemcitabine; Chemotherapy; Pancreatectomy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1363 / 1371
页数：8
相关论文
共 50 条
  • [41] Does Axl have potential as a therapeutic target in pancreatic cancer?
    Du, Wenting
    Brekken, Rolf A.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2018, 22 (11) : 955 - 966
  • [42] TMS1 as a potential therapeutic target of pancreatic cancer
    Miller, H.
    Ramachandran, K.
    Gordian, E.
    Lima, C. S. Rocha
    Singal, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [43] Integrative Analysis Identified MCT4 as an Independent Prognostic Factor for Bladder Cancer
    Zhao, Yang
    Zhao, Bin
    Yan, Wei-Hua
    Xia, Yan
    Wang, Zhi-Hui
    Zheng, Guo-Yang
    Wang, Wen-Da
    Zhang, Yu-Shi
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [44] Survivin is a Potential New Therapeutic Target in the Treatment of Pancreatic Cancer
    Ly, Q. P.
    Person, J. J.
    Teggart, C. A.
    Mathiesen, M. R.
    Howell, G. M.
    Brattain, M. G.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S154 - S154
  • [45] Hepatocyte growth factor: a potential therapeutic target in pancreatic cancer
    Arun, S. J.
    Xu, Z.
    Fiala-Beer, E.
    Yang, L.
    Phillips, P.
    Goldstein, D.
    Biankin, A.
    Pirola, R.
    Wilson, J. S.
    Apte, M. V.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 20 - 20
  • [46] A novel siRNA-gemcitabine construct as a potential therapeutic for treatment of pancreatic cancer
    Simonenko, Vera
    Lu, Xiaoyong
    Roesch, Eric
    Mutisya, Daniel
    Shao, Chunbo
    Sun, Qian
    Patterson-Orazem, Athena
    McNair, Marcus
    Shanmuganathan, Aranganathan
    Lu, Patrick
    Evans, David M.
    NAR CANCER, 2020, 2 (03):
  • [47] Girdin Knockdown Increases Gemcitabine Chemosensitivity to Pancreatic Cancer by Modulating Autophagy
    Wang, Sheng
    Feng, Wei
    Wang, Wulin
    Ye, Xiaoman
    Chen, Hao
    Yu, Chunzhao
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [48] Stromal glycolysis and MCT4 are hallmarks of DCIS progression to invasive breast cancer
    Lisanti, Michael P.
    Sotgia, Federica
    Pestell, Richard G.
    Howell, Anthony
    Martinez-Outschoorn, Ubaldo E.
    CELL CYCLE, 2013, 12 (18) : 2935 - +
  • [49] Coexpression of MCT1 and MCT4 in ALK-positive Anaplastic Large Cell Lymphoma Diagnostic and Therapeutic Implications
    Choi, Jung-Woo
    Lee, Youngseok
    Kim, Hyunchul
    Cho, Hyun Yee
    Min, Soo Kee
    Kim, Young-Sik
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2022, 46 (02) : 241 - 248
  • [50] Evaluation of Therapeutic Response to Gemcitabine in Pancreatic Cancer
    Suetomi, Yoichiro
    Kitano, Masayuki
    Kudo, Masatoshi
    Sakamoto, Hiroki
    Maekawa, Kiyoshi
    HEPATO-GASTROENTEROLOGY, 2008, 55 (86-87) : 1785 - 1788
12345